当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析 - 现金流量表

山东药玻

(600529)

  

流通市值:121.51亿  总市值:121.51亿
流通股本:6.64亿   总股本:6.64亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,139,397,765.114,490,886,217.833,978,406,212.712,615,291,303.22
  收到的税费返还140,883.9729,831,962.5230,073,176.5427,151,453.11
  收到其他与经营活动有关的现金5,351,512.8734,545,180.320,695,673.7812,593,334.84
  经营活动现金流入小计1,144,890,161.954,555,263,360.654,029,175,063.032,655,036,091.17
  购买商品、接受劳务支付的现金608,617,445.542,642,662,182.712,555,957,541.181,700,775,028.38
  支付给职工以及为职工支付的现金222,736,160.18832,623,235.74607,553,128.39417,648,227.44
  支付的各项税费77,251,624.03315,561,608.8235,697,495.85173,279,219.52
  支付其他与经营活动有关的现金23,295,480.98187,491,370.04119,010,369.3963,892,869.18
  经营活动现金流出小计931,900,710.733,978,338,397.293,518,218,534.812,355,595,344.52
  经营活动产生的现金流量净额212,989,451.22576,924,963.36510,956,528.22299,440,746.65
二、投资活动产生的现金流量:
  收回投资收到的现金2,290,000,0007,990,000,0006,130,000,0004,370,000,000
  取得投资收益收到的现金5,914,095.8430,074,799.5624,510,053.3416,034,426.49
  处置固定资产、无形资产和其他长期资产收回的现金净额76,2103,197,307.22,188,587.21,658,760
  投资活动现金流入小计2,295,990,305.848,023,272,106.766,156,698,640.544,387,693,186.49
  购建固定资产、无形资产和其他长期资产支付的现金211,041,960.34231,864,537.19385,042,423.88233,845,660.91
  投资支付的现金820,000,0007,940,000,0006,130,000,0004,340,000,000
  投资活动现金流出小计1,031,041,960.348,171,864,537.196,515,042,423.884,573,845,660.91
  投资活动产生的现金流量净额1,264,948,345.5-148,592,430.43-358,343,783.34-186,152,474.42
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-370,341,793.4370,341,793.4180,554,602.56
  支付其他与筹资活动有关的现金2,079,383.316,408,210.17--
  筹资活动现金流出小计2,079,383.31376,750,003.57370,341,793.4180,554,602.56
  筹资活动产生的现金流量净额-2,079,383.31-376,750,003.57-370,341,793.4-180,554,602.56
四、汇率变动对现金及现金等价物的影响-5,991,709.375,793,613.617,322,055.647,833,614.04
五、现金及现金等价物净增加额1,469,866,704.0457,376,142.97-210,406,992.88-59,432,716.29
  加:期初现金及现金等价物余额942,557,504.68885,181,361.71885,181,361.71885,181,361.71
  期末现金及现金等价物余额2,412,424,208.72942,557,504.68674,774,368.83825,748,645.42
补充资料:
  净利润-689,626,040.66-371,141,622
  资产减值准备-156,894,172.13-48,839,146.75
  固定资产和投资性房地产折旧-382,906,229.57-193,580,334.75
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-382,906,229.57-193,580,334.75
  无形资产摊销-6,763,498.71-3,367,732.88
  处置固定资产、无形资产和其他长期资产的损失--1,452,467.75--417,482.36
  固定资产报废损失-5,756,957.92-3,305,455.91
  公允价值变动损失--9,136,242.46--6,447,381.91
  财务费用--5,304,673.54--7,833,614.04
  投资损失--17,548,332.44--7,227,203.39
  递延所得税--17,331,349.14--15,314,856.45
  其中:递延所得税资产减少--17,331,349.14--15,314,856.45
  存货的减少--520,117,827.63--311,626,265.06
  经营性应收项目的减少-299,248,910.05-159,305,280.05
  经营性应付项目的增加--390,259,010.65--133,678,731.5
  其他--4,585,106.93--2,013,132.91
  不涉及现金收支的投资和筹资活动金额其他项目-43,422,548.42--
  现金的期末余额-942,557,504.68-825,748,645.42
  减:现金的期初余额-885,181,361.71-885,181,361.71
  现金及现金等价物的净增加额-57,376,142.97--59,432,716.29
公告日期2026-04-252026-03-072025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑